These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6254782)

  • 1. Inhibition of growth in young mice treated with pentazocine: reversal by naltrexone.
    Wassef NM; Smith AA
    Eur J Pharmacol; 1980 Aug; 66(2-3):155-60. PubMed ID: 6254782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition by d,l-methadone of RNA and protein synthesis in neonatal mice: antagonism by naloxone or naltrexone.
    Hui FW; Krikun E; Smith AA
    Eur J Pharmacol; 1978 May; 49(1):87-93. PubMed ID: 658129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of growth in young mice treated with d,1-methadone.
    Smith AA; Hui FW; Crofford MJ
    Eur J Pharmacol; 1977 Jun; 43(4):307-14. PubMed ID: 880978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Butorphanol, levallorphan, nalbuphine and nalorphine as antagonists in the squirrel monkey.
    Dykstra LA
    J Pharmacol Exp Ther; 1990 Jul; 254(1):245-52. PubMed ID: 2164093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and chronic morphine administration: effects of mixed-action opioids in rats and squirrel monkeys responding under a schedule of food presentation.
    Oliveto AH; Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1991 Apr; 257(1):8-18. PubMed ID: 1850479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opiate receptor pharmacology: mixed agonist/antagonist narcotics.
    Hameroff SR
    Contemp Anesth Pract; 1983; 7():27-43. PubMed ID: 6136392
    [No Abstract]   [Full Text] [Related]  

  • 7. Naltrexone reduces weight gain, alters "beta-endorphin", and reduces insulin output from pancreatic islets of genetically obese mice.
    Recant L; Voyles NR; Luciano M; Pert CB
    Peptides; 1980; 1(4):309-13. PubMed ID: 6272240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The irreversible narcotic antagonistic and reversible agonistic properties of the fumaramate methyl ester derivative of naltrexone.
    Takemori AE; Larson DL; Portoghese PS
    Eur J Pharmacol; 1981 Apr; 70(4):445-51. PubMed ID: 6263637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naltrexone modulates body and brain development in rats: a role for endogenous opioid systems in growth.
    Zagon IS; McLaughlin PJ
    Life Sci; 1984 Nov; 35(20):2057-64. PubMed ID: 6092812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naltrexone modulates growth in infant rats.
    Zagon IS; McLaughlin PJ
    Life Sci; 1983 Dec; 33(24):2449-54. PubMed ID: 6316064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of naloxone and naltrexone on locomotor activity in C57BL/6 and DBA/2 mice.
    Castellano C; Puglisi-Allegra S
    Pharmacol Biochem Behav; 1982 Apr; 16(4):561-3. PubMed ID: 6280203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous development of opioid tolerance and opioid antagonist-induced receptor upregulation.
    Yoburn BC; Sierra V; Lutfy K
    Brain Res; 1990 Oct; 529(1-2):143-8. PubMed ID: 2178026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible role of dopamine in the growth inhibitory effect of pentazocine.
    Gandhi IC; Vajpeyee S; Shah UH; Dikshit RK; Doctor RB
    Dev Pharmacol Ther; 1983; 6(2):138-44. PubMed ID: 6305611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential naltrexone antagonism of hydromorphone and pentazocine effects in human volunteers.
    Preston KL; Bigelow GE
    J Pharmacol Exp Ther; 1993 Feb; 264(2):813-23. PubMed ID: 7679737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of morphine, nalbuphine and pentazocine on gastric emptying of indigestible solids.
    Asai T
    Arzneimittelforschung; 1998 Aug; 48(8):802-5. PubMed ID: 9748706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative antagonism by naltrexone and naloxone of mu, kappa, and delta agonists.
    Takemori AE; Portoghese PS
    Eur J Pharmacol; 1984 Sep; 104(1-2):101-4. PubMed ID: 6094203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precipitated withdrawal by pentazocine in methadone-maintained volunteers.
    Strain EC; Preston KL; Liebson IA; Bigelow GE
    J Pharmacol Exp Ther; 1993 Nov; 267(2):624-34. PubMed ID: 7504098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naloxone and naltrexone: actions and interactions at an opiate drug receptor on frog skeletal muscle fibers.
    Frank GB; Marwaha J
    J Pharmacol Exp Ther; 1979 Jun; 209(3):382-8. PubMed ID: 220407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of naloxone and naltrexone to antagonize halothane anesthesia in the dog.
    Pace NL; Wong KC
    Anesth Analg; 1979; 58(1):36-9. PubMed ID: 219728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nalbuphine, a mixed kappa 1 and kappa 3 analgesic in mice.
    Pick CG; Paul D; Pasternak GW
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1044-50. PubMed ID: 1326621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.